Our Curious Amalgam

323 Episodo

1. #241 Are PBMs Good For Competition? A Cost-Benefit Analysis of the Effects of Regulating Pharmacy Benefit Managers

   Publicado: 2/10/2023
2. #240 Can Competition and Quality Coincide? Analyzing a Systematic Competition Law Approach to Healthcare and Quality Concerns

   Publicado: 25/9/2023
3. #239 No More Clouds on the Horizon? The UK CMA’s Investigation Into Microsoft’s Acquisition of Activision Blizzard

   Publicado: 18/9/2023
4. #238 Who Is Fiona Schaeffer? Meet the New Chair of the ABA Antitrust Law Section

   Publicado: 11/9/2023
5. #237 Should We Bank on Changes? A Conversation About Bank Merger Policy

   Publicado: 4/9/2023
6. #236 What Is PE Anyway? All the Questions You Were Afraid To Ask About Private Equity

   Publicado: 28/8/2023
7. #235 Win, Lose, or Draw? A Decade of Pharma Antitrust Since FTC vs. Actavis

   Publicado: 21/8/2023
8. #234 What About Small Tech? Democratizing Employment Data

   Publicado: 14/8/2023
9. #233 What Are the Thoughts Behind the Changes? Draft DOJ-FTC Merger Guidelines Explained by DOJ DAAGs

   Publicado: 7/8/2023
10. #232 Never a Dull Moment In Antitrust? Conversation With Judge Douglas Ginsburg

    Publicado: 31/7/2023
11. #231 What’s Happening in MENA? Trends and Developments in Middle East and Egyptian Antitrust

    Publicado: 24/7/2023
12. #230 Will That Be Cash or Credit? Swipe Fees and Their Critics

    Publicado: 17/7/2023
13. #229 What’s Happening in the EU? A Conversation with DG COMP Director-General Olivier Guersent at the 2023 Spring Meeting

    Publicado: 10/7/2023
14. #228 What's Happening in Canada, Brazil, and Taiwan? Conversations With Competition Law Enforcers at the 2023 Spring Meeting

    Publicado: 3/7/2023
15. #227 Axin’ the FTC’s Administrative Authority? The Implications of Axon Enterprise, Inc. v. FTC

    Publicado: 26/6/2023
16. #226 An Agency in Peril? The Implications of Axon, Louisiana Children’s Medical Center, and Other Challenges to the FTC’s Power

    Publicado: 19/6/2023
17. #225 A New Syllabus For Antitrust Class? Meet the Authors of the New Open Source U.S. Antitrust Law Casebook

    Publicado: 12/6/2023
18. #224 What’s Happening in Austria, Switzerland, and Lithuania? Conversations With Competition Law Enforcers at the 2023 Spring Meeting.

    Publicado: 5/6/2023
19. #223 Are Chatbots Protected? Analyzing Whether Section 230 Should Apply to Generative AI.

    Publicado: 29/5/2023
20. #222 Too Political or Not Political Enough? A Debate on the Relationship Between Antitrust Enforcement and Democracy.

    Publicado: 22/5/2023